Results 141 to 150 of about 2,709,664 (338)

Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate

open access: yesFundamental &Clinical Pharmacology, Volume 39, Issue 4, August 2025.
ABSTRACT Chronic kidney disease (CKD) affects over 10% of the world's population and is associated with high morbidity and mortality rates. The management of CKD is complex; CKD alters drug pharmacokinetics and pharmacodynamics and further complicates therapeutic strategies regimens.
Sophie Liabeuf   +6 more
wiley   +1 more source

Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice.

open access: yesPLoS ONE, 2018
Epidemiological studies have linked vitamin D deficiency to an increased incidence of myocardial infarction and support a role for vitamin D signalling in the pathophysiology of myocardial infarction.
Kristopher Ford   +7 more
doaj   +1 more source

An Update: Enzymatic Synthesis for Industrial Applications

open access: yesAngewandte Chemie International Edition, Volume 64, Issue 27, July 1, 2025.
Biocatalysis has become a sustainable and cost‐competitive alternative to established chemical synthesis, enabling the enzyme‐based production of not only commodity chemicals but (non‐natural) amino acids, (rare) sugars, as well as synthetic nucleotides.
Thomas Bayer   +4 more
wiley   +1 more source

Osteitis Fibrosa Cystica; A Forgotten Manifestation of Secondary Hyperparathyroidism Due to End-Stage Renal Disease: A Case Report

open access: yesInternational Medical Case Reports Journal, 2022
Semir Abdi Usmael,1 Sisay Molla Ansa,1 Derejie Woldesilasie Tufa2 1Department of Internal Medicine, Haramaya University, College of Health and Medical Science, Harar, Ethiopia; 2Department of Radiology, Haramaya University, College of Health and Medical ...
Usmael SA, Ansa SM, Tufa DW
doaj  

Secondary hyperparathyroidism in patient with type 2 diabetes and stages 3–4 chronic kidney disease

open access: yesСахарный диабет, 2018
Secondary hyperparathyroidism is an early complication of chronic kidney disease, with increasing severity as the glomerular filtration rate decreases and characterized by a progressive increase in parathyroid hormone and growth of the parathyroid glands.
Lilit V. Egshatyan   +1 more
doaj   +1 more source

Mucolipidosis II presenting as severe neonatal hyperparathyroidism [PDF]

open access: yes, 2018
Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture ...
Braverman, Nancy   +9 more
core  

Racial Differences in Secondary Hyperparathyroidism

open access: yesNephro-Urology Monthly, 2013
Dear Editor, I have recently read an interesting paper by Dr. Seck who had examined the prevalence of CKD-MBD in black African (Senegalese) patients on regular hemodialysis (HD) in a cross-sectional fashion (Nephrol-Urol Mon. 2012; 4(4): 613-616) (1).
openaire   +4 more sources

Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons’ Society of Japan

open access: yesTherapeutic apheresis and dialysis, 2016
Secondary hyperparathyroidism (SHPT) remains a serious complication in patients with chronic kidney disease, and some patients require parathyroidectomy.
Y. Tominaga   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy